Literature DB >> 14745567

Comparative analysis of the benefits of autotransfusion of blood by a shed blood collector after total knee replacement.

Ely L Steinberg1, Peleg Ben-Galim, Yona Yaniv, Shmuel Dekel, Aharon Menahem.   

Abstract

INTRODUCTION: Joint replacement is associated with massive blood loss. Various techniques have been used to avoid the use of allogeneic blood. One of the techniques used is postoperative salvage and reinfusion of shed blood that was found to reduce the use of banked blood with its potential risk.
MATERIALS AND METHODS: We prospectively studied 365 patients who underwent knee joint replacement (TKR) and were divided in two groups. Group A's shed blood (SureTrans System) was collected ( n=194) and reinfused and group B's was not ( n=171, "controls"). Hemoglobin levels before and after the operation were recorded.
RESULTS: Allogeneic blood requirement for TKR decreased by 65% in group A compared to group B. The packed cell/patient index dropped from 0.91 to 0.29 in group 2A. Statistical analysis yielded the odds ratio for blood replacement, a "predicting formula" for blood replacement depending on hemoglobin levels, and a cutoff point for a patient's receiving blood replacement.
CONCLUSION: We recommend using this system in TKR for decreasing allogeneic blood replacement and potential associated risks. The predicting formula for blood replacement may be a helpful tool when making a decision of whether or not to use the collector system and for whom.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745567     DOI: 10.1007/s00402-003-0629-2

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  9 in total

1.  Acute compartment syndrome of the forearm following autologous blood reinfusion: a case report.

Authors:  Matthew Noyes; Michael J Coffey; Dennis M Brown; Homayoun Mesghali
Journal:  Hand (N Y)       Date:  2009-10-29

2.  The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study.

Authors:  A Zacharopoulos; A Apostolopoulos; A Kyriakidis
Journal:  Int Orthop       Date:  2006-06-30       Impact factor: 3.075

3.  Effectiveness of an autologous transfusion system following cemented and non-cemented revisions of total hip arthroplasty.

Authors:  Nael Hawi; Daniel Oliver Kendoff; Udo Hessling; Carl Haasper; Thorsten Gehrke; Mustafa Citak
Journal:  Int Orthop       Date:  2014-05-11       Impact factor: 3.075

4.  Does single use of an autologous transfusion system in TKA reduce the need for allogenic blood?: a prospective randomized trial.

Authors:  Johannes Cip; Mark Widemschek; Thomas Benesch; Roman Waibel; Arno Martin
Journal:  Clin Orthop Relat Res       Date:  2012-12-11       Impact factor: 4.176

5.  Reinfusion of unwashed salvaged blood after total knee arthroplasty in patients with rheumatoid arthritis.

Authors:  Keiji Matsuda; Masahiko Nozawa; Sadanobu Katsube; Katsuhiko Maezawa; Hisashi Kurosawa
Journal:  Int Orthop       Date:  2008-10-14       Impact factor: 3.075

6.  Comparison between autologous blood transfusion drainage and closed-suction drainage/no drainage in total knee arthroplasty: a meta-analysis.

Authors:  Kun-Hao Hong; Jian-Ke Pan; Wei-Yi Yang; Ming-Hui Luo; Shu-Chai Xu; Jun Liu
Journal:  BMC Musculoskelet Disord       Date:  2016-08-01       Impact factor: 2.362

7.  Post-operative auto-transfusion in total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.

Authors:  Zhao Haien; Jiang Yong; Ma Baoan; Guo Mingjun; Fan Qingyu
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

8.  Postoperative Autologous Reinfusion in Total Knee Replacement.

Authors:  A Crescibene; F Martire; P Gigliotti; A Rende; M Candela
Journal:  J Blood Transfus       Date:  2015-09-09

9.  Are reinfusion drains safe to use with periarticular liposomal bupivacaine? An analysis of systemic bupivacaine toxicity.

Authors:  Marc R Angerame; Gavin P Hart; Susan M Odum; Bryan D Springer
Journal:  Arthroplast Today       Date:  2017-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.